A parametric study delineating irreversible electroporation from thermal damage based on a minimally invasive intracranial procedure

BioMedical Engineering Online

Volumn 10, Issue , 2011, Pages

  Garcia, Paulo A ^a   Rossmeisl Jr, John H ^b   Neal II, Robert E ^a   Ellis, Thomas L ^c   Davalos, Rafael V ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APPLIED VOLTAGES; EFFECTS OF TEMPERATURE; ELECTRODE CONFIGURATIONS; ELECTROPORATION; IN-VIVO; MINIMALLY INVASIVE; MINIMALLY-INVASIVE TECHNIQUE; NONTHERMAL; NUMERICAL SIMULATION; OUTCOME ASSESSMENT; PARAMETRIC STUDY; PHYSICAL EFFECTS; PULSE DURATIONS; PULSE FREQUENCIES; PULSE PARAMETER; REPETITION RATE; THERMAL DAMAGE; TISSUE ABLATIONS; TOMOGRAPHIC; TREATMENT PLANNING; TREATMENT VOLUMES;

COMPUTERIZED TOMOGRAPHY; NUMERICAL METHODS; RATING; TISSUE;

PULSE REPETITION RATE;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BRAIN; CYTOLOGY; DOG; ELECTRIC CONDUCTIVITY; ELECTROPORATION; HEAT; TIME;

ANIMALS; BRAIN; DOGS; ELECTRIC CONDUCTIVITY; ELECTROPORATION; HOT TEMPERATURE; MODELS, BIOLOGICAL; TIME FACTORS;

EID: 79955381998     PISSN: 1475925X     EISSN: 1475925X     Source Type: Journal    
DOI: 10.1186/1475-925X-10-34     Document Type: Article

References (59)

1. Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P, Davalos RV, Rubinsky B, Mir LM. Tumor ablation with irreversible electroporation. PLoS ONE 2007, 2(11):e1135. 10.1371/journal.pone.0001135, 2065844, 17989772.
2. Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B. In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 2006, 53(7):1409-15. 10.1109/TBME.2006.873745, 16830945.
3. Lee EW, Loh CT, Kee ST. Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat 2007, 6(4):287-94.
4. Davalos RV, Mir LM, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005, 33(2):223-31. 10.1007/s10439-005-8981-8, 15771276.
5. Rubinsky B. Irreversible Electroporation in Medicine. Technology in Cancer Research and Treatement 2007, 6(4):255-260.
6. Miklavcic D, Semrov D, Mekid H, Mir LM. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochimica et Biophysica Acta 2000, 1523(1):73-83.
7. Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G. The importance of electric field distribution for effective in vivo electroporation of tissues. Biophysical Journal 1998, 74(5):2152-2158. 10.1016/S0006-3495(98)77924-X, 1299558, 9591642.
8. Edd JF, Davalos RV. Mathematical modeling of irreversible electroporation for treatment planning. Technology in Cancer Research and Treatment 2007, 6:275-286.
9. Guo Y, Zhang Y, Klein R, Nijm GM, Sahakian AV, Omary RA, Yang GY, Larson AC. Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res 2010, 70(4):1555-63. 10.1158/0008-5472.CAN-09-3067, 2822885, 20124486.
10. Neal RE, Singh R, Hatcher HC, Kock ND, Torti SV, Davalos RV. Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode. Breast Cancer Res Treat 2010, 123(1):295-301. 10.1007/s10549-010-0803-5, 3021965, 20191380.
11. Garcia PA, Pancotto T, Rossmeisl JH, Henao-Guerrero N, Gustafson NR, Daniel GB, Robertson JL, Ellis TL, Davalos RV. Non-thermal irreversible electroporation (NTIRE) and adjuvant fractionated radiotherapeutic multimodal therapy for intracranial malignant glioma in a canine patient. Technol Cancer Res Treat 2011, 10(1):73-83.
12. Neal RE, Rossmeisl JH, Garcia PA, Lanz OI, Henao-Guerrero N, Davalos RV. Successful Treatment of a Large Soft Tissue Sarcoma With Irreversible Electroporation. J Clin Oncol 2011, 14:14.
13. Davalos RV, Rubinsky B, Mir LM. Theoretical analysis of the thermal effects during in vivo tissue electroporation. Bioelectrochemistry 2003, 61(1-2):99-107. 10.1016/j.bioelechem.2003.07.001, 14642915.
14. Davalos RV, Rubinsky B. Temperature considerations during irreversible electroporation. International Journal of Heat and Mass Transfer 2008, 51(23-24):5617-5622.
15. Tropea BI, Lee RC. Thermal injury kinetics in electrical trauma. J Biomech Eng 1992, 114(2):241-50. 10.1115/1.2891378, 1602768.
16. Lee RC, Zhang D, Hannig J. Biophysical injury mechanisms in electrical shock trauma. Annual Review of Biomedical Engineering 2000, 2(1):477-509. 10.1146/annurev.bioeng.2.1.477, 11701521.
17. Becker SM, Kuznetsov AV. Numerical modeling of in vivo plate electroporation thermal dose assessment. Journal of Biomechanical Engineering 2006, 128(1):76-84. 10.1115/1.2132375, 16532620.
18. Shafiee H, Garcia PA, Davalos RV. A Preliminary Study to Delineate Irreversible Electroporation From Thermal Damage Using the Arrhenius Equation. Journal of Biomechanical Engineering 2009, 131(7):074509. 10.1115/1.3143027, 19640145.
19. Lackovic I, Magjarevic R, Miklavcic D. Three-dimensional finite-element analysis of joule heating in electrochemotherapy and in vivo gene electrotransfer. IEEE Transactions on Dielectrics and Electrical Insulation 2009, 16(5):1338-1347.
20. Pliquett U. Joule heating during solid tissue electroporation. Med Biol Eng Comput 2003, 41(2):215-9. 10.1007/BF02344892, 12691444.
21. Ellis TL, Garcia PA, Rossmeisl JH, Henao-Guerrero N, Robertson J, Davalos RV. Nonthermal irreversible electroporation for intracranial surgical applications. J Neurosurg 2011, 114:681-688. 10.3171/2010.5.JNS091448, 20560725.
22. Garcia PA, Rossmeisl JH, Neal RE, Ellis TL, Olson J, Henao-Guerrero N, Robertson J, Davalos RV. Intracranial nonthermal irreversible electroporation: In vivo analysis. J Membr Biol 2010, 236(1):127-136. 10.1007/s00232-010-9284-z, 20668843.
23. Garcia PA, Neal RE, Rossmeisl JH, Davalos RV. Non-thermal irreversible electroporation for deep intracranial disorders. Conf Proc IEEE Eng Med Biol Soc 2010, 1:2743-6.
24. Lee EW, Thai S, Kee ST. Irreversible Electroporation: A Novel Image-Guided Cancer Therapy. Gut Liver 2010, 4(Suppl 1):S99-S104. 2989557, 21103304.
25. Ball C, Thomson KR, Kavnoudias H. Irreversible electroporation: a new challenge in "out of operating theater" anesthesia. Anesth Analg 2010, 110(5):1305-9. 10.1213/ANE.0b013e3181d27b30, 20142349.
26. Pech M, Janitzky A, Wendler JJ, Strang C, Blaschke S, Dudeck O, Ricke J, Liehr UB. Irreversible Electroporation of Renal Cell Carcinoma: A First-in-Man Phase I Clinical Study. Cardiovasc Intervent Radiol 2010,
27. Onik G, Rubinsky B. Irreversible Electroporation. Irreversible Electroporation: First Patient Experience Focal Therapy of Prostate Cancer 2010, 235-247. Springer Berlin Heidelberg, Onik G, Rubinsky B.
28. Garcia PA, Rossmeisl JH, Robertson J, Ellis TL, Davalos RV. Pilot study of irreversible electroporation for intracranial surgery. Conf Proc IEEE Eng Med Biol Soc 2009, 1:6513-6.
29. Latikka J, Kuurne T, Eskola H. Conductivity of living intracranial tissues. Phys Med Biol 2001, 46(6):1611-6. 10.1088/0031-9155/46/6/302, 11419622.
30. Davalos RV, Otten DM, Mir LM, Rubinsky B. Electrical impedance tomography for imaging tissue electroporation. IEEE Transactions on Biomedical Engineering 2004, 51(5):761-767. 10.1109/TBME.2004.824148, 15132502.
31. Ivorra A, Rubinsky B. In vivo electrical impedance measurements during and after electroporation of rat liver. Bioelectrochemistry 2007, 70(2):287-95. 10.1016/j.bioelechem.2006.10.005, 17140860.
32. Sel D, Cukjati D, Batiuskaite D, Slivnik T, Mir LM, Miklavcic D. Sequential finite element model of tissue electropermeabilization. IEEE Trans Biomed Eng 2005, 52(5):816-27. 10.1109/TBME.2005.845212, 15887531.
33. Ivorra A, Al-Sakere B, Rubinsky B, Mir LM. In vivo electrical conductivity measurements during and after tumor electroporation: conductivity changes reflect the treatment outcome. Phys Med Biol 2009, 54(19):5949-63. 10.1088/0031-9155/54/19/019, 19759406.
34. Miklavcic D, Snoj M, Zupanic A, Kos B, Cemazar M, Kropivnik M, Bracko M, Pecnik T, Gadzijev E, Sersa G. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. BioMedical Engineering OnLine 2010, 9(1):10. 10.1186/1475-925X-9-10, 2843684, 20178589.
35. Pavselj N, Bregar Z, Cukjati D, Batiuskaite D, Mir LM, Miklavcic D. The course of tissue permeabilization studied on a mathematical model of a subcutaneous tumor in small animals. IEEE Trans Biomed Eng 2005, 52(8):1373-81. 10.1109/TBME.2005.851524, 16119232.
36. Sel D, Lebar AM, Miklavcic D. Feasibility of employing model-based optimization of pulse amplitude and electrode distance for effective tumor electropermeabilization. IEEE Trans Biomed Eng 2007, 54(5):773-81.
37. Cukjati D, Batiuskaite D, Andre F, Miklavcic D, Mir LM. Real time electroporation control for accurate and safe in vivo non-viral gene therapy. Bioelectrochemistry 2007, 70(2):501-7. 10.1016/j.bioelechem.2006.11.001, 17258942.
38. Becker SM, Kuznetsov AV. Thermal damage reduction associated with in vivo skin electroporation: A numerical investigation justifying aggressive pre-cooling. International Journal of Heat and Mass Transfer 2007, 50:105-116.
39. Duck FA. Physical Properties of Tissues: A Comprehensive Reference Book 1990, San Diego: Academic Press.
40. Werner J, Buse M. Temperature profiles with respect to inhomogeneity and geometry of the human body. J Appl Physiol 1988, 65(3):1110-8.
41. Uzuka T, Tanaka R, Takahashi H, Kakinuma K, Matsuda J, Kato K. Planning of hyperthermic treatment for malignant glioma using computer simulation. Int J Hyperthermia 2001, 17(2):114-22. 10.1080/02656730010010676, 11252356.
42. Cosman ER, Cosman ER. Electric and thermal field effects in tissue around radiofrequency electrodes. Pain Med 2005, 6(6):405-24. 10.1111/j.1526-4637.2005.00076.x, 16336478.
43. Diller KR. Modeling of bioheat transfer processes at high and low temperatures. Bioengineering heat transfer 1992, 32:157-357. Boston: Academic Press, Inc, Choi YI.
44. Sherar MD, Moriarty JA, Kolios MC, Chen JC, Peters RD, Ang LC, Hinks RS, Henkelman RM, Bronskill MJ, Kucharcyk W. Comparison of thermal damage calculated using magnetic resonance thermometry, with magnetic resonance imaging post-treatment and histology, after interstitial microwave thermal therapy of rabbit brain. Phys Med Biol 2000, 45(12):3563-76. 10.1088/0031-9155/45/12/304, 11131184.
45. Henriques FC, Moritz AR. Studies in thermal injuries: the predictability and the significance of thermally induced rate processes leading to irreversible epidermal damage. Arch Pathol 1947, 43:489-502.
46. Diller KR, Hayes LJ. A finite element model of burn injury in blood-perfused skin. J Biomech Eng 1983, 105(3):300-7. 10.1115/1.3138423, 6632835.
47. Jiang SC, Ma N, Li HJ, Zhang XX. Effects of thermal properties and geometrical dimensions on skin burn injuries. Burns 2002, 28(8):713-7. 10.1016/S0305-4179(02)00104-3, 12464468.
48. Brown SL, Hunt JW, Hill RP. Differential thermal sensitivity of tumor and normal tissue microvascular response during hyperthermia. International Journal of Hyperthermia 1992, 8(4):501-514. 10.3109/02656739209037988, 1402130.
49. Borrelli MJ, Thompson LL, Cain CA, Dewey WC. Time-temperature analysis of cell killing of BHK cells heated at temperatures in the range of 43.5 degrees C to 57.0 degrees C. International Journal of Radiation Oncology Biology Physics 1990, 19(2):389-399.
50. Jacques SL, Newman C, He XY. Thermal coagulation of tissues: liver studies indicate a distribution of rate parameters, not a single rate parameter, describes the coagulation process. Advances in Biological Heat and Mass Transfer by New York: ASME: J McGrath 1991, 71-73.
51. Neal RE, Davalos RV. The feasibility of irreversible electroporation for the treatment of breast cancer and other heterogeneous systems. Ann Biomed Eng 2009, 37(12):2615-25. 10.1007/s10439-009-9796-9, 19757056.
52. Kos B, Zupanic A, Kotnik T, Snoj M, Sersa G, Miklavcic D. Robustness of treatment planning for electrochemotherapy of deep-seated tumors. J Membr Biol 2010, 236(1):147-53. 10.1007/s00232-010-9274-1, 20596859.
53. Zupanic A, Corovic S, Miklavcic D. Optimization of electrode position and electric pulse amplitude in electrochemotherapy. Radiol Oncol 2008, 42(2):93-101.
54. Nicolaidis S. Neurosurgical treatments of intractable pain. Metabolism 2010, 59(Suppl 1):S27-31.
55. Jarm T, Cemazar M, Miklavcic D, Sersa G. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Review of Anticancer Therapy 2010, 10(5):729-746. 10.1586/era.10.43, 20470005.
56. Sersa G, Cemazar M, Miklavcic D, Chaplin DJ. Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Research 1999, 19(5B):4017-4022.
57. Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, Miklavcic D, Kadivec M, Kranjc S, Secerov A, Cemazar M. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. British Journal of Cancer 2008, 98(2):388-398. 10.1038/sj.bjc.6604168, 2361464, 18182988.
58. Pethig R. Dielectric Properties of Biological Materials: Biophysical and Medical Applications. IEEE Transactions on Electrical Insulation 1984, EI-19(5):453-474.
59. Foster KR, Schwan HP. Dielectric properties of tissues and biological materials: a critical review. Crit Rev Biomed Eng 1989, 17(1):25-104.